文献速递脑血管病头痛与眩晕

内源性凝血途径、头痛史与缺血性卒中风险

Intrinsic Coagulation Pathway, History of Headache, and Risk of Ischemic Stroke.
PubMed 文献 · Stroke · 2019-07-09

基于荷兰人群的RATIO病例对照研究纳入113例50岁以下女性缺血性卒中和598名健康对照,19%有头痛史。头痛与内源性凝血蛋白高水平(除FXII抗原和两种FXIa抑制剂外)联合时,卒中风险高于两者单独效应之和,提示可能存在生物学交互作用。

要点

  • 年轻女性中头痛史与内源性凝血蛋白高水平可能交互增加缺血性卒中风险。
  • FXI抗原水平单独aOR 1.7,头痛单独aOR 2.0,两者联合aOR 5.2。
  • 临床评估年轻女性卒中风险时可关注头痛史与凝血指标的联合效应。

核心结论

  • 头痛与内源性凝血蛋白高水平可能发生生物学交互作用,增加缺血性卒中风险。

研究设计与样本

  • 荷兰人群为基础的病例对照研究(RATIO研究),纳入50岁以下女性缺血性卒中病例113例和健康对照598名。
  • 头痛史通过问卷定义,内源性凝血蛋白通过抗原水平(FXII、FXI、前激肽释放酶、高分子量激肽原)和蛋白活化水平测定。

主要发现

  • 共134例(19%)有头痛史,其中病例38例、对照96例。
  • 头痛合并内源性凝血蛋白高水平(除FXII抗原水平和两种FXIa抑制剂外)与缺血性卒中风险的增加高于两者单独效应之和。
  • FXI抗原水平单独aOR 1.7(95%CI 1.0-2.9),头痛单独aOR 2.0(95%CI 1.1-3.7),两者联合aOR 5.2(95%CI 2.3-11.6)。

关键数值与推荐

  • FXI抗原水平单独aOR 1.7(95%CI 1.0-2.9)。
  • 头痛单独aOR 2.0(95%CI 1.1-3.7)。
  • 头痛与FXI抗原水平联合aOR 5.2(95%CI 2.3-11.6)。

临床怎么用

  • 对年轻女性缺血性卒中风险评估时,可考虑头痛史与内源性凝血指标的联合作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Hypercoagulable states in migraine patients may play a role in the pathophysiology underlying the association between migraine and ischemic stroke. This study aims to provide more insight into the potential association of headache, ischemic stroke, and the intrinsic coagulation pathway. Methods- We included patients from the RATIO study (Risk of Arterial Thrombosis in Relation to Oral Contraceptives), a Dutch population-based case-control study including young women (age <50) with ischemic stroke and healthy controls. We defined a headache group based on a questionnaire on headache history. Intrinsic coagulation proteins were measured through both antigen levels (FXII, FXI, prekallikrein, HK [high molecular weight kininogen]) and protein activation, determined by measuring activated protein complex with C1esterase-inhibitor (FXIIa-C1-INH, FXIa-C1-INH, Kallikrein-C1-INH) or antitrypsin-inhibitor (FXIa-AT-INH). We calculated adjusted odds ratios and performed an interaction analysis assessing the increase in stroke risk associated with high levels of intrinsic coagulation and history of headache. Results- We included 113 ischemic stroke cases and 598 healthy controls. In total, 134 (19%) patients had a history of headache, of whom 38 were cases and 96 controls. The combination of headache and high intrinsic coagulation protein levels (all but FXII antigen level and both FXIa-inhibitors) was associated with an increase in ischemic stroke risk higher than was expected based on their individual effects (adjusted odds ratio FXI antigen level alone: 1.7, 95% CI, 1.0-2.9; adjusted odds ratio headache alone: 2.0, 95% CI, 1.1-3.7; combination: 5.2, 95% CI, 2.3-11.6) Conclusions- Headache and high intrinsic coagulation protein levels may biologically interact, increasing risk for ischemic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. van Os HJA, Wermer MJH, Rosendaal FR, et al. Intrinsic Coagulation Pathway, History of Headache, and Risk of Ischemic Stroke. Stroke. 2019. PMID: 31284847. doi:10.1161/STROKEAHA.118.023124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。